Defining criteria for macrophage activation syndrome, a process towards early recognition and treatment

Journal of Rheumatology

Volumn 38, Issue 4, 2011, Pages 593-594

  Wulffraat, Nico M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; CORTICOSTEROID; CYCLOSPORIN; ETOPOSIDE; INTERLEUKIN 2 RECEPTOR; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EARLY DIAGNOSIS; EARLY INTERVENTION; EDITORIAL; ERYTHROPHAGOCYTOSIS; FEVER; HEPATOMEGALY; HUMAN; HYPERFERRITINEMIA; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY TEST; MACROPHAGE ACTIVATION SYNDROME; PRIORITY JOURNAL; SYMPTOM;

ARTHRITIS, JUVENILE RHEUMATOID; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGE ACTIVATION SYNDROME;

EID: 79953313603     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.101269     Document Type: Editorial

References (15)

1. Diamantberger MS. Du rhumatisme noueux (polyarthrite deformante) chez les enfants [thesis]. University of Paris; 1891. [Internet. Accessed January 11, 2011.] Available from: http://worldcat.org/oclc/14782325
2. Still GF. On a form of chronic joint disease in children. Med Chir Trans 1897;80:47-59.
3. Allantaz F, Chaussabel D, Stichweh D, Bennett L, Allman W, Mejias A, et al. Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade. J Exp Med 2007;204:2131-44. (Pubitemid 47360874)
4. de Jager W, Hoppenreijs EPAH, Wulffraat NM, Wedderburn LR, Kuis W, Prakken BJ. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis 2007;66:589-98. (Pubitemid 46707126)
5. de Jager W, Vastert SJ, Beekman JM, Wulffraat NM, Kuis W, Coffer PJ, et al. Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2009;60:2782-93.
6. Grom AA, Villanueva J, Lee S, Goldmuntz EA, Passo MH, Filipovich A. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr 2003;142:292-6. (Pubitemid 36338013)
7. Ramanan AV, Schneider R. Macrophage activation syndrome - what's in a name! J Rheumatol 2003;30:2513-6.
8. Ravelli A, Magni-Manzoni S, Pistorio A, Besana C, Foti T, Ruperto N, et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 2005;146:598-604. (Pubitemid 40616243)
9. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-31. (Pubitemid 44958267)
10. Miettunen PM, Narendran A, Jayanthan A, Behrens EM, Cron RQ. Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients. Rheumatology 2011;50:417-9.
11. Nigrovic PA, Mannion M, Prince FH, Zeft A, Rabinovich CE, van Rossum MA, et al. Anakinra as first-line disease modifying therapy in systemic juvenile idiopathic arthritis. Arthritis Rheum 2010 Nov 4. [Epub ahead of print]
12. Swart JF, Barug D, Mohlmann M, Wulffraat NM. The efficacy and safety of interleukin-1-receptor antagonist anakinra in the treatment of systemic juvenile idiopathic arthritis. Expert Opin Biol Ther 2010;10:1743-52.
13. Davi S, Consolaro A, Guseinova D, Pistorio A, Ruperto N, Martini A, et al. An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol 2011;38:764-8.
14. Behrens EM, Beukelman T, Paessler M, Cron RQ. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol 2007;34:1133-8. (Pubitemid 46774861)
15. Grom AA, Mellins ED. Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol 2010;22:561-6.